Dr Reddys Laboratories (RDY) Times Interest Earned (2009 - 2016)

Dr Reddys Laboratories (RDY) posted quarterly Times Interest Earned of $1.9 for Q4 2016, down 89.13% quarter-over-quarter from $17.5 in Q1 2013.

Dr Reddys Laboratories (RDY) Times Interest Earned (2009 - 2016) Analysis & Trends

Dr Reddys Laboratories' Times Interest Earned history runs 5 years deep, the most recent figure standing at $1.9 for Q4 2016.

In Q4 2016, Times Interest Earned changed N/A year-over-year to $1.9; the TTM figure through Sep 2017 stood at $9.29 (changed N/A YoY), while the FY2026 annual figure was $13.48, down 47.19% from the prior year.
Times Interest Earned for Q4 2016 stood at $1.9, down from $17.5 in the prior quarter.
The five-year high for Times Interest Earned was $68.0 million in Q4 2012, with the low at $1.9 in Q4 2016.
The 3-year median for Times Interest Earned is $17.5 (2013), against an average of $22.7 million.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn	-
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-3.15
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	114.07
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	0.05
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	52.24
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	4.20
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	-
10	Alkermes	8.12 Bn	7.46 Bn	397.90 Mn	0.71

Download Data